TELA Bio (TELA)
(Delayed Data from NSDQ)
$1.62 USD
+0.03 (1.89%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.62 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth B Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TELA 1.62 +0.03(1.89%)
Will TELA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TELA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TELA
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates
TELA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
NeoGenomics (NEO) Meets Q2 Earnings Estimates
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
Other News for TELA
TELA forms MACD Bullish Signal Line Cross on September 19
Stochastic Buy Signal appears for TELA after 5.3% move
TELA forms 20 Day Moving Average Resistance on September 17
Sideways movement on September 16 results in no shift to TELA’s technical outlook
Is TELA signaling selling opportunity? 20 Day Moving Average Resistance shows up after a flat session